Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT06773663
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Phase 1/2
- Enrolled
- 150 participants
- Registry
-
NCT06773663
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT06773663. Allocation not applicable; no masking; primary purpose diagnostic. Start 2023-12-30 (actual); primary completion 2026-05-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism
- Condition
- Primary Aldosteronism
- Condition
- Primary Aldosteronism Due to Aldosterone Producing Adenoma
- Intervention (Combination product)
- Al18F-NOTA-Pentixafor PET/CT
- Lead sponsor
- Peking Union Medical College Hospital
Record details
- Record id
cardio:ct-nct06773663- Content hash
56a60ae3eee5b553e60dcd6827684b04b9eee5c2976abc26f3598352740a65ae